Statin treatment and the risk of recurrent pulmonary embolism

Abstract

Statin treatment decreases the risk of recurrent PE, irrespective of VKA treatment. Treatment with statins may be an attractive alternative for anticoagulant treatment in the long-term treatment of PE.